ArticleCancer science2020

CD4/CD8 ratio is a prognostic factor in IgG nonresponders among peptide vaccine-treated ovarian cancer patients.

Kayoko Waki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.